ArticleFrontiers in immunology2021

A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains.

Fengxia Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.